Wealthfront Advisers LLC decreased its holdings in HCA Healthcare Inc (NYSE:HCA) by 8.2% in the first quarter, HoldingsChannel reports. The firm owned 8,879 shares of the company’s stock after selling 797 shares during the period. Wealthfront Advisers LLC’s holdings in HCA Healthcare were worth $1,158,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare during the 4th quarter valued at $25,000. Sontag Advisory LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter worth about $26,000. Doyle Wealth Management purchased a new stake in shares of HCA Healthcare in the 4th quarter worth about $31,000. Financial Gravity Wealth Inc. purchased a new stake in shares of HCA Healthcare in the 1st quarter worth about $47,000. Finally, JOYN Advisors Inc. lifted its position in shares of HCA Healthcare by 83.3% in the 4th quarter. JOYN Advisors Inc. now owns 460 shares of the company’s stock worth $57,000 after purchasing an additional 209 shares during the period. 70.29% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently commented on HCA. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 target price for the company. in a research report on Monday, May 27th. UBS Group raised their target price on shares of HCA Healthcare from $164.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Deutsche Bank raised their target price on shares of HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Raymond James raised shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $115.00 to $135.00 in a research report on Tuesday, April 23rd. Finally, Jefferies Financial Group set a $158.00 target price on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, April 17th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and eighteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $149.00.
Shares of HCA Healthcare stock traded down $0.35 during trading on Friday, hitting $127.03. The company’s stock had a trading volume of 14,876 shares, compared to its average volume of 1,557,228. The firm has a market cap of $43.74 billion, a price-to-earnings ratio of 12.99, a PEG ratio of 1.02 and a beta of 0.76. HCA Healthcare Inc has a 52 week low of $101.30 and a 52 week high of $147.42.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.31 by $0.66. The company had revenue of $12.52 billion during the quarter, compared to analyst estimates of $12.34 billion. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. HCA Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the business earned $3.18 EPS. Equities analysts anticipate that HCA Healthcare Inc will post 10.4 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Monday, June 3rd will be paid a $0.40 dividend. The ex-dividend date is Friday, May 31st. This represents a $1.60 annualized dividend and a dividend yield of 1.26%. HCA Healthcare’s payout ratio is 16.38%.
In related news, insider Jon M. Foster sold 44,281 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the transaction, the insider now directly owns 96,052 shares in the company, valued at approximately $11,745,238.56. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.70% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Stock Observer and is owned by of Stock Observer. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.thestockobserver.com/2019/06/14/wealthfront-advisers-llc-cuts-stake-in-hca-healthcare-inc-nysehca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: What is the Coverage Ratio?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.